Henderson Jane
CIK 1422304
Transactions on file
13
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-17 | 2026-04-16 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,000 | $180.0K | -1.9% | open → |
| 2025-06-05 | 2025-06-03 | AKRO Akero Therapeutics, Inc. | Director | Grant | 9,398 | $0.00 | — | open → |
| 2026-05-05 | 2026-05-01 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 289 | $24.0K | +6.2% | open → |
| 2026-05-05 | 2026-05-01 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 900 | $74.3K | +6.9% | open → |
| 2026-05-05 | 2026-05-01 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 811 | $65.7K | +9.0% | open → |
| 2025-12-23 | 2025-12-19 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,500 | $120.0K | +10.4% | open → |
| 2025-12-09 | 2025-12-09 | AKRO Akero Therapeutics, Inc. | Disp. | 9,398 | $0.00 | — | open → | |
| 2025-12-05 | 2025-12-04 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,500 | $112.5K | +17.8% | open → |
| 2025-11-28 | 2025-11-25 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,500 | $105.0K | +26.2% | open → |
| 2025-11-14 | 2025-11-14 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,000 | $130.0K | +35.9% | open → |
| 2025-11-13 | 2025-11-11 | APGE Apogee Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,000 | $60.0K | +47.2% | open → |
| 2025-08-12 | 2025-08-12 | AKRO Akero Therapeutics, Inc. | Director | Exer. | 3,000 | $21.0K | — | open → |
| 2025-08-12 | 2025-08-12 | AKRO Akero Therapeutics, Inc. | Director | Sale | 3,000 | $142.4K | — | open → |
